Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene expression-based biomarkers designating glioblastomas resistant to multiple treatment strategies

20 Mar 2021

Abstract excerpt

Despite advances in molecular characterization of glioblastoma multiforme (GBM), only a handful of predictive biomarkers exist with limited clinical relevance. We aimed to identify differentially expressed genes in tumor samples collected at surgery associated with response to subsequent treatment, including temozolomide (TMZ) and nitrosoureas. Gene expression was collected from multiple independent datasets....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Metastases and Treatment
Share to Chromatin Remodeling and Cancer
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33754151
DOI: 10.1093/carcin/bgab024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene expression-based biomarkers designating glioblastomas resistant to multiple treatment strategiesPMID 33754151Read ↗

Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of GlioblastomasSemantic proximity Read ↗

Identification of Differentially Expressed Genes in Different Glioblastoma Regions and Their Association with Cancer Stem Cell Development and Temozolomide ResponseSemantic proximity Read ↗

Identification of a panel of genes as a prognostic biomarker for glioblastomaSemantic proximity Read ↗

Expression Profiling of Glioblastoma Cell Lines Reveals Novel Extracellular Matrix-Receptor Genes Correlated With the Responsiveness of Glioma Patients to Ionizing RadiationSemantic proximity Read ↗

A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenibSemantic proximity Read ↗

A multigene predictor of outcome in glioblastomaSemantic proximity Read ↗

Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinibSemantic proximity Read ↗

Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular dataSemantic proximity Read ↗

Development and Validation of a Novel DNA Methylation-Driven Gene Based Molecular Classification and Predictive Model for Overall Survival and Immunotherapy Response in Patients With Glioblastoma: A Multiomic AnalysisSemantic proximity Read ↗

Identification of novel drug resistance mechanisms by genomic and transcriptomic profiling of glioblastoma cells with mutation-activated EGFR.Semantic proximity Read ↗

Gene Expression Patterns Associated with Survival in GlioblastomaSemantic proximity Read ↗

Exploring Responses of Glioblastoma Patient-Derived Cell Cultures to Drugs Reveals New Therapeutic OpportunitiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.